<DOC>
	<DOCNO>NCT00907114</DOCNO>
	<brief_summary>The purpose study determine efficacy safety topic ketorolac treatment center point thickness secondary panphotocoagulation proliferative diabetic retinopathy .</brief_summary>
	<brief_title>Topic Ketorolac Added Panphotocoagulation Proliferative Diabetic Retinopathy</brief_title>
	<detailed_description>Panphotocoagulation standard treatment proliferative diabetic retinopathy 3 4 session within 2 week . This treatment reduce incidence severe visual loss long term . Nonetheless , induce macular thickness delay conclusion treatment . This delay could coincide vitreous hemorrhage , turn , may limit additional photocoagulation . Topic ketorolac could limit inflammatory reaction cause panphotocoagulation produce early benefit patient .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>type 2 diabetes proliferative diabetic retinopathy without macular edema adequate quality 6 mm fast macular map day treatment visual capacity subjective refraction treatment sign inform consent ocular surgery last 4 month myopia 6.00 diopter allergy ketorolac nonsteroid antiinflammatory previous selective photocoagulation use nonsteroid antiinflammatory immunomodulators intraocular inflammatory retinal disease different diabetic retinopathy pregnancy actual corneal disease inadequate quality 6 mm fast macular map second visit inconsistency second visit adverse event drug remove inform consent</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>proliferative diabetic retinopathy</keyword>
	<keyword>macular edema</keyword>
	<keyword>panphotocoagulation</keyword>
	<keyword>topic ketorolac</keyword>
	<keyword>efficacy</keyword>
	<keyword>treatment</keyword>
</DOC>